The Impact of Drug Discontinuation in Patients Treated with Temporary Pacemaker Due to Atrioventricular Block
- 19 July 2013
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 24 (11) , 1255-1258
Abstract
The Impact of Drug Discontinuation in Patients: Introduction: Patients treated with a temporary pacemaker (TPM) due to atrioventricular (AV) block are often monitored after discontinuation of AV node blocking drugs to evaluate the indication for permanent pacing. However, the impact of drug discontinuation is sparsely documented. We investigated to what extent drug discontinuation abolished the need for permanent pacemaker (PPM) implantation.Methods and Results: All hospital records of patients who received a TPM at Aalborg Hospital, Denmark, between January 2000 and March 2011 (n = 575) were retrospectively reviewed. Patients with AV block who were treated with a TPM and concomitant cessation of drug therapy were included if there was no other underlying mechanism causing the AV block. AV blocking drugs included antiarrhythmic agents classes II–IV and digoxin. Fifty‐five patients fulfilled our inclusion criteria.Forty‐seven patients had an indication for a PPM at the initial hospital admission, despite drug discontinuation. Of the remaining 8 patients who were discharged without a PPM, 3 subsequently experienced events: 2 had recurrence of AV block requiring a PPM, and 1 experienced syncope. Thus, in total, 49 (89%) patients had a final indication for a permanent pacemaker (PPM).Of patients receiving beta‐blocker monotherapy, 26 (96%) had an indication for a PPM. TPM implantation was complicated by infection or displacement in 11% of cases.Conclusions: The vast majority of patients treated with a TPM due to AV block and who receive beta‐blockers alone or in combination with digoxin have a final indication for a PPM despite cessation of drug treatment. TPM are frequently associated with complications.Keywords
This publication has 10 references indexed in Scilit:
- Prognosis and Natural History of Drug-Related BradycardiaKorean Circulation Journal, 2009
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesJACC, 2008
- High-degree atrioventricular block during anti-arrhythmic drug treatment: use of a pacemaker with a bradycardia-detection algorithm to study the time course after drug withdrawalEP Europace, 2007
- Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drugJACC, 2004
- DigitalisCirculation, 1999
- Effects of beta-adrenergic receptor stimulation and blockade on rate-dependent atrioventricular nodal properties.Circulation Research, 1992
- The Effects of Slow Channel Blockers and Beta Blockers on Atrioventricular Nodal ConductionThe Journal of Clinical Pharmacology, 1988
- Electrophysiological effects of cardioselective and non‐cardioselective beta‐adrenoceptor blockers with and without ISA at rest and during exercise.British Journal of Clinical Pharmacology, 1982
- His bundle electrocardiography in digitalis-induced “atrioventricular junctional” Wenckebach periods with irregular H-H intervalsThe American Journal of Cardiology, 1979
- Effects of digitalis on ventricular myocardial and His-Purkinje refractoriness and reentry in manThe American Journal of Cardiology, 1978